Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1β post-translational processing

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 57-64

  Perregaux, David G ^a   Svensson, Linne ^a   Gabel, Christopher A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 (1 PHENYLINDOL 3 YL)ACRYLIC ACID; 6 CHLORO 2,3 DIHYDRO 3 METHYL 3 (2 THIENYLCARBONYL) 2 OXO 1H INDOLE 1 CARBOXAMIDE; 6 CHLORO 3 [(4 CHLORO 2 THIENYL)HYDROXYMETHYLENE] 5 FLUORO 2,3 DIHYDRO 2 OXO 1H INDOLE 1 CARBOXAMIDE; CP 100829; CP 236492; INTERLEUKIN 1BETA; TENIDAP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANION TRANSPORT; ANTIGEN PRESENTATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PROCESSING;

ANIMALS; ANIONS; CARRIER PROTEINS; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; INDOLES; INTERLEUKIN-1; ION TRANSPORT; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0029892934     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Dinarello, C. A. 1994. The biological properties of interleukin-1. Eur. Cytokine Netw. 5:517.
2. Arend, W. P., and J.-M. Dayer. 1995. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 38:151.
3. Wakabayashi, G., J. A. Gelfand, J. F. Burke, R. C. Thompson, and C. A. Dinarello. 1991. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5:338.
4. van den Berg, W. B., L. A. Joosten, M. Helsen, and F. A. van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol 95:237.
5. Lee, J. C., A. M. Badger, D. E. Griswold, D. Dunnington, A. Truneh, B. Votta, J. R. White, P. R. Young, and P. E. Bender. 1993. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann. NY Acad. Sci. 696:149.
6. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld. E. Towne, D. Tracey, S. Wardwell, F.-Y. Wei, W. Wong, R. Kamen, and T. Seshadri. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401.
7. Sims, J. E., and S. K. Dower. 1994. Interleukin-1 receptors. Eur. Cytokine Netw. 5:539.
8. Giri, J. G., P. T. Lomedico, and S. B. Mizel. 1985. Studies on the synthesis and secretion of interleukin 1. J Immunol. 134:343.
9. Hazuda, D. J., J. C. Lee, and P. R. Young. 1988. The kinetics of interleukin 1 secretion from activated monocytes. J. Biol. Chem. 263:8473.
10. Mizutani, H., R. Black, and T. S. Kupper. 1991. Human keratinocytes produce but do not process pro-interleukin-1 beta. J. Clin. Invest. 87:1066.
11. Elias, J. A., M. M. Reynolds. R. M. Kotloff, and J. A. Kern. 1989. Fibroblast interleukin 1β: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation. Proc. Natl. Acad. Sci. USA 86:6171.
12. Rubartelli, A., F. Cozzolino, M. Talio, and R. Sitia,. 1990. A novel secretory pathway for interleukin-1β, a protein lacking a signal sequence. EMBO J. 9:1503.
13. March, C. J., B. Mosley, A. Larsen, D. P. Cerretti, G. Braedt, V. Price, S. Gillis, C. S. Henney, S. R. Kronheim, K. Grabstein, P. J. Conlon, T. P. Hopp, and D. Cosman. 1985 Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641.
14. Maier, J. A. M., M. Statuto, and G. Ragnotti. 1994. Endogenous interleukin-1 alpha must be transported to the nucleus to exert its activity in human endothelial cells. Mol. Cell Biol. 14:1845.
15. Brooks, J. W., and S. B. Mizel. 1994. Interleukin-1 signal transduction. Eur. Cytokine Netw. 5:547.
16. Mosley, B., D. L. Urdal, K. S. Prickett, A. Larsen, D. Cosman, P. J. Conlon, S. Gillis, and S. K. Dower 1987. The interleukin-1 receptor binds the human interleukin-1α precursor but not the interleukin-1β precursor. J. Biol. Chem. 262: 2941.
17. Cerretti, D. P., C. J. Kozlosky, B. Bosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R., Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, and R. A. Black. 1992. Molecular cloning of the interleukin-1β converting enzyme. Science 256:97.
18. Ayala, J. M., T.-T. Yamin, L. A. Egger, J. Chin, M. J. Kostura, and D. K. Miller. 1994. IL-1β-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J. Immunol. 153:2592.
19. Giri, J. G., P. T. Lomedico, and S. B. Mizel. 1985. Studies on the synthesis and secretion of interleukin 1. J. Immunol. 134:343.
20. Howard, A. D., M. J. Kostura, N. Thornberry, G. J. F. Ding, G. Limjuco, J. Weidner, J. P. Salley, K. A. Hogquist, D. D. Chaplin, R. A. Mumford, J. A. Schmidt, and M. J. Tocci. IL-1 converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-kDa IL-1α. J. Immunol. 147:2964.
21. Hogquist, K. A., M. A. Nett, E. R. Unanue, and D. D. Chaplin. 1991. Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 88:8485.
22. Perregaux, D., J. Barberia, A. J. Lanzetti, K. F. Geoghegan, T. J. Carty, and C. A. Gabel. 1992. IL-1β maturation; evidence that mature cytokine formation can be induced specifically by nigericin. J. Immunol. 149:1294.
23. Bhakdi, S., M. Muhly, S. Korom, and G. Schmidt. 1990. Effects of Escherichia coli hemolysin on human monocytes. J. Clin. Invest. 85:1746.
24. Perregaux, D., and C. A. Gabel. 1994. Interleukin-1β maturation and release in response to ATP and nigericin. J. Biol. Chem. 269:15195.
25. Walev, I., K. Reske, M. Palmer, A. Valeva, and S. Bhakdi. 1995. Potassiuminhibited processing of IL-1β in human monocytes. EMBO J. 14:1607.
26. Laliberte, R., D. Perregaux, L. Svensson, C. J. Pazoles, and C. A. Gabel. 1994. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1β production from ATP-treated monocytes and macrophages. J. Immunol. 153:2168.
27. Podack, E. R., H. Hengertner, and M. G. Lichtenheld. 1991. A central role of perform in cytolysis. Annu. Rev. Immunol. 9:129.
28. Masson, D., and J. Tschopp. 1987. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 49:679.
29. Irmler, M., S. Hertig, H. R. MacDonald., R. Sadoul, J. D. Becherer, A. Proudfoot, R. Solari, and J. Tschopp. 1995. Granzyme A is an interleukin 1β-converting enzyme. J. Exp. Med. 181:1917.
30. McNiff, P., L. Svensson, C. J. Pazoles, and C. A. Gabel. 1994. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance. J. Immunol. 153:2180.
31. McNiff, P. A., R. E. Laliberte, L. Svensson, C. J. Pazoles, and C. A. Gabel. 1995. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. Cytokine 7:196.
32. McNiff, P. A., R. Robinson, and C. A. Gabel. 1995. Reduction of intracellular pH by tenidap: involvement of cellular anion transporters in the pH change. Biochem. Pharmacol. 50:1421.
33. - channel inhibitors. Am. J. Physiol. 265:C143.
34. Halestrap, A. P. 1975. The mitochondrial pyruvate carrier: kinetics and specificity for substrates and inhibitors. Biochem. J. 148:85.
35. - efflux from human neutrophils. Biochem. Pharmacol. 45:1743.
36. 4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Eicosanoids 1:35.
37. Carty, C. J., J. D. Eskra, J. G. Lombardino, and W. W. Hoffman. 1980. Piroxicam, a potent inhibitor of prostaglandin production in cell culture: structure-activity study. Prostaglandins 19:51.
38. Jimenez, A. 1976. Inhibitors of translation. Trends Biochem. Sci. 1:28.
39. Bhakdi, S., M. Muhly, S. Korom, and F. Hugo, 1989. Release of interleukin-1β associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect. Immun. 57:3512.
40. Buisman, H. P., T. H. Steinberg, J. Fischbarg, S. C. Silverstein, S. A. Vogelzang, C. Ince, D. L. Ypey, and P. C. J. Leijh. 1988. Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes. Proc. Natl. Acad. Sci. USA 85:7988.
41. 2Z receptor of human macrophage cells: characterization and possible physiological role. J. Clin. Invest. 95:1207.
42. Andersson, M., H. Gunne, B. Agerberth, R. Sillard, H. Jornvall, V. Mutt, B. Olsson, H. G. Boman, and G. H. Gudmundsson. 1995. NK-lysin, a novel effector peptide of cytotoxic T and NK cells: structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumor activity. EMBO J. 14:1615.
43. Di Virgilio, F., P. Pizzo, P. Zanovello, V. Bronte, and D. Collavo. 1990. Extracellular ATP as a possible mediator of cell-mediated cytoxicity. Immunol. Today 11:274.
44. Blanchard, D. K., S. Wei, C. Duan, F. Pericle, J. I. Diaz, and J. Y. Djeu. 1995. Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood 85:3173.
45. Black, R. A., S. R. Kronheim, and P. R. Sleath. 1989. Activation of interleukin-1β by a co-induced protease. FEBS Lett. 247:386.
46. Howard, A. D., O. C. Palyha, P. R. Griffin, E. P. Peterson, A. B. Lenny, G. J.-F. Ding, D. J. Pickup, N. A. Thornberry, J. A. Schmidt, and M. J. Tocci. 1995. Human IL-1β processing and secretion in recombinant baculovirus-infected Sf9 cells is blocked by the cowpox virus serpin crmA. J. Immunol. 154:2321.
47. Korchack, H. M., B. A. Eisenstat, S. T. Hoffstein, P. B. Dunham, and G. Weissmann. 1980. Anion channel blockers inhibit lysosomal enzyme secretion from human neutrophils without affecting generation of superoxide anion. Proc. Natl. Acad. Sci. USA 77:2721.
48. Conklyn, M. S., S. B. Kadin, and H. J. Showell. 1990. Inhibition of IgE-mediated N-acetylglucosaminidase and seratonin release from rat basophilic leukemia cells (RBL2H3) by tenidap: a novel antiinflammatory agent. Int. Arch. Allergy Appl. Immunol. 91:369.
49. + cytotoxic T cell induce apoptosis of APC. Eur. J. Immunol. 22:267.
50. Gray, L. S., and J. H. Russell. 1986. Cytolytic T lymphocyte effector function requires plasma membrane chloride flux. J. Immunol. 136:3032.
51. Loose, L. D., J. D. Sipe, D. S. Kirby, A. R. Kraska, E. S. Weiner, W. R. Shanahan, and P. Farrow. 1992. Inhibition of acute phase protein production by tenidap - a new antirheumatic agent. Br. J. Rheumatol. 31(Suppl.):257.
52. Littman, B. H., C. E. Drury, and C. R. Stewart. 1993. Acute phase proteins and plasma IL-6 in patients with rheumatoid arthritis: effects of tenidap and piroxicam in a 12 week double-blind crossover study. Arthritis Rheum. 36(Suppl.):S112.
53. Sipe, J. D., L. M. Bartle, and L. D. Loose. 1992. Modification of proinflammatory cytokine production by antirheumatic agents tenidap and naproxen: a possible correlate with clinical acute phase response. J. Immunol. 148:480.
54. Otterness, I. G., M. L. Bliven, J. T. Downs, E. J. Natoli, and D. C. Hanson. 1991. Inhibition of interleukin 1 synthesis by tenidap: a new drug for arthritis. Cytokine 3:277.
55. Griffiths, G. M., S. Alpert, E. Lambert, J. McGuire, and I. L. Weissman. 1992. Perform and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 89:549.
56. Chikanza, I. C., G. Kingsley, and G. S. Panayi. 1995. Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J. Rheumatol. 22:600.